Investor mix
4 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Private equity | 2 | 50% |
| Bank & private debt | 1 | 25% |
A molecular diagnostics company specializing in genomic medicine solutions
4 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Private equity | 2 | 50% |
| Bank & private debt | 1 | 25% |